Company Overview
COMPASS THERAPEUTICS, INC.
CMPXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-66M
2025 FY
Shares Outstanding
158M
2025 FY
EPS
-0.42USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1738021
Exchange
Nasdaq
Location
US